Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism P2Y14 antagonists(purinergic receptor P2Y14 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H24F3NO2 |
InChIKeyPXJXLYRJAGOTQU-DFZDUAMZSA-N |
CAS Registry2801625-42-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | US | 24 Feb 2022 |